Search by Drug Name or NDC

    NDC 45737-0210-16 Bionatuss 2; 20; 10 mg/5mL; mg/5mL; mg/5mL Details

    Bionatuss 2; 20; 10 mg/5mL; mg/5mL; mg/5mL

    Bionatuss is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Advanced Generic Corporation. The primary component is DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 45737-0210
    Product ID 45737-210_2c36395e-c0a5-42a6-ba75-977b33b65aac
    Associated GPIs 43995803500920
    GCN Sequence Number 052995
    GCN Sequence Number Description d-methorphan/pe/dexbromphenir SYRUP 20-10-2/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 20305
    HICL Sequence Number 025559
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL/DEXBROMPHENIRAMINE
    Brand/Generic Generic
    Proprietary Name Bionatuss
    Proprietary Name Suffix DXP
    Non-Proprietary Name Dexbrompheniramine Maleate, Dextromethorphan, Phenylephrine
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 2; 20; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Advanced Generic Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 45737-0210-16 (45737021016)

    NDC Package Code 45737-210-16
    Billing NDC 45737021016
    Package 473 mL in 1 BOTTLE (45737-210-16)
    Marketing Start Date 2009-10-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL e57de19a-bf2f-405c-bc84-6ccae6055a46 Details

    Revised: 12/2020